TAXIS Pharmaceuticals
Phase 1Your Content Goes Here Learn More Antimicrobial resistance is projected to kill up to 10 million people a year by 2050. We won’t let this happen. TAXIS Pharmaceuticals is developing investigational therapies to combat antimicrobial resistance – we're addressing the root causes of the issue and targeting the very foundation of
About
Your Content Goes Here Learn More Antimicrobial resistance is projected to kill up to 10 million people a year by 2050. We won’t let this happen. TAXIS Pharmaceuticals is developing investigational therapies to combat antimicrobial resistance – we're addressing the root causes of the issue and targeting the very foundation of
Funding History
2Total raised: $8.5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile